Cite
HARVARD Citation
Innocenti, I. et al. (2018). Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia. Hematological oncology. 36 (3), pp. 600-603. [Online].